Capula Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Capula Management's AMGN Position: Q1 2026 in Review
Capula Management reduced its Amgen (AMGN) stake by 100% in Q1 2026, selling an estimated $39.2M and leaving 61 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.
Capula Management first reported a position in AMGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $93.6M in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capula Management held 61 shares of Amgen worth $21.5K as of Q1 2026.
- Capula Management sold 109,965 Amgen shares in Q1 2026, an estimated $39.2M.
- Amgen made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1039 holding.
- Capula Management first reported a position in Amgen in Q1 2021 and has held it in 16 quarters since.
- Capula Management's Amgen position peaked at $93.6M in Q1 2025.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.